ElevateBio picks up $525m Series C

ElevateBio, a cell and gene therapy technology company, has raised $525 million in Series C financing.

ElevateBio, a cell and gene therapy technology company, has raised $525 million in Series C financing. Matrix Capital Management led the round.

Source: Press Release